Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
DNA Vaccines Market: By Type, By Application, By Technology and Geography
DNA Vaccines Market: By Type, By Application, By Technology and Geography
DNA Vaccines Market size is valued at US$ 453.4 million in 2022 and is poised to grow at a CAGR of 6.6% from 2023 - 2029. DNA vaccination is a method for shielding an individual against illness by vaccinating it with genetically engineered DNA, so cells directly manufacture an antigen, ensuing in a defensive immunological response. It contains delivering genes or fragments of it, training immunogenic antigens to the cells of the host by utilizing DNA plasmids as a vector. This method encourages both cell-mediated and humoral immune responses efficiently. DNA vaccines are third-generation vaccines precisely designed to overcome the unsolicited possessions of conventional vaccines. The surge in the vulnerability of the population to communicable diseases and the growth in a number of antibiotic-resistant pathogens have created the necessity for low-cost and effective vaccination, which would deliver immunity for a longer time period. The global market provides a detailed overview of the DNA Vaccines market size, and that can be segmented by type, by application, and by technology. By type, the DNA Vaccines market growth has been segmented into Animal DNA vaccine and Human DNA vaccine. The animal DNA vaccine segment is likely to be the significant growing segment in terms of type. Based on Application, the DNA Vaccines market is segmented into Human application and Veterinary applications. Among these, the Human application segment is expected to have a significant growing market during the forecast period 2022-2028. Based on the technology, the DNA Vaccines market is segmented Plasmid DNA vaccines and Plasmid DNA delivery. The Plasmid DNA Preparation delivery segment is expected to have a significant share in 2021.
DNA Vaccines Market Key Developments:
Study Period
2024-2030Base Year
2023CAGR
6.6%Largest Market
North-AmericaFastest Growing Market
Europe
The increase in the prevalence of infectious and cancer diseases in humans and animals increase in the need for DNA vaccines due to their advantages are anticipated to propel the market growth over the forecast years. Moreover, the surge in number of antibiotics resistant pathogens is burgeoning the market growth over the forecast years.
North America market is expected to witness the highest market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 453.4 million |
|
Market CAGR |
6.6% |
|
By Type |
|
|
By Technology |
|
|
By Application |
|
Download Free Sample Report
growth of new vaccines using DNA technology, and high potential for growth in unexploited developing economies.
lack of immunogenicity related with DNA vaccines
On February 2022, Alvea launched a shelf-stable DNA vaccine against the new SARS- CoV-2.
Easy DNA vaccine product approval and presence of key players in these regions
Table of Content
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.